Stocks to sell

For years, investing in growth stocks was the key to building an incredible long-term portfolio. Investing in such stocks resulted in oversized returns, which enabled investors to build a robust portfolio. However, given the wild market gyrations, growth stocks have dipped to multi-year lows. Though this may seem like an excellent opportunity, it’s more prudent
0 Comments
Suffice it to say, microprocessor manufacturer Intel (NASDAQ:INTC) stock has disappointed its investors for the majority of 2022. However, financial traders went into a feeding frenzy with INTC stock after the company reported its quarterly earnings. They apparently ignored a number of issues that Intel is still facing. Furthermore, one analyst reaffirmed a $20 price target
0 Comments
Although an uncomfortable subject based on financial sensitivities, the topic of Nasdaq stocks to avoid cannot be avoided much longer. To be clear, it’s not so much about the companies specifically. Rather, with the Federal Reserve committed to its hawkish monetary policy, borrowing costs will rise. With that, the incentive for expansion-driven protocols will likely
0 Comments
Based in New York, Mind Medicine (NASDAQ:MNMD) is a psychedelic-medicine developer that’s sometimes informally known as MindMed. Before investing in this company, it’s important to know that MNMD stock was previously out of compliance with the Nasdaq exchange’s listing requirements. This is a problem that could happen again in the near future. Moreover, Mind Medicine is
0 Comments
With fears of a global recession rising, it’s probably best to consider targeting certain Nasdaq stocks to sell. Though the underlying technology-centric exchange brings several innovators to the table, many of these ideas don’t align with traditional strengths. In particular, some publicly traded companies feature the worst of both worlds: high risk and overvalued. Since
0 Comments